Search

Search Results
Results 7071 - 7080 of 7123 for autoimmune
  • White Paper - 10 Nov 2021
    Anti-idiotypic antibodies, often known as anti-drug antibodies, are important references for immunogenicity analysis. They are incredibly useful in pharmacokinetics research. ACROBiosystems offers a...
  • White Paper - 10 Nov 2021
    In this article, ACROBiosystems discusses Fc receptors, which are glycoproteins that are becoming increasingly important in immunotherapy. ACRO discusses how they’re classified and their functions...
  • White Paper - 6 Mar 2019
    Using an APCI LC-MS/MS mass spectrometry system to perform the analysis of vitamin D in cheese.
  • Health - 27 Feb 2019
    Rickets has been around for centuries, but its roots as a symptom of vitamin D deficiency began only in the 17th century, when Francis Glisson published his findings on the disease and proposed that...
  • News - 18 Feb 2010
    Incyte Corporation today reported fourth quarter and full year 2009 financial results, provided an update on key fourth quarter accomplishments and 2010 objectives, and announced its 2010 financial...
  • Drug - 15 Aug 2025
    Consumer Medicine Information (CMI) about Tysabri intended for persons living in Australia.
  • Drug - 14 Aug 2025
    Consumer Medicine Information (CMI) about Tevimbra intended for persons living in Australia.
  • Drug - 13 Aug 2025
    Consumer Medicine Information (CMI) about Ultomiris 100mg/ml intended for persons living in Australia.
  • Drug - 6 Aug 2025
    Consumer Medicine Information (CMI) about Abrilada intended for persons living in Australia.
  • Drug - 2 Jun 2025
    Consumer Medicine Information (CMI) about Shingrix intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.